Life Science News

RSS

Specific gene variants influence dental symptoms in rare bone condition

In hypophosphatasia, a rare inherited condition that weakens bones and teeth, early tooth loss can be the first, or even the only obvious sign.

6 Oct 2026

Terumo announces global commercial launch of K-Pack Embrace™ active safety needle

Terumo Corporation today announced the global commercial launch of its K-Pack Embrace™ active safety needle.

From Terumo Corporation 6 Oct 2026

Terumo Blood and Cell Technologies partners with TrAMPoline Pharma to automate TIL therapy manufacturing for solid tumors

Terumo Blood and Cell Technologies (Terumo BCT), a medical technology company advancing blood- and cell-based therapies worldwide, has entered a research collaboration with TrAMPoline Pharma and Eduardo Davila, PhD, at the University of Colorado to develop an automated manufacturing approach for tumor-infiltrating lymphocyte (TIL) therapies targeting solid tumors.

6 Oct 2026

Before the first bite: A missing gut protein may set the stage for peanut allergy

For most people, a peanut butter sandwich poses no threat. But for the roughly 1.6 million children in the United States with peanut allergy, exposure can trigger a life-threatening reaction.

6 Oct 2026

Lipid signaling pathway helps cells survive bacterial toxin damage

Epithelial cells form the body's frontline barriers, helping keep microbes, toxins, and other harmful substances out.

5 Oct 2026

New BCR analysis method tracks immune recovery after stem cell transplantation

A research team led by Associate Professor Yohei Funakoshi, Associate Professor Kimikazu Yakushijin, and Professor Hironobu Minami of the Division of Medical Oncology/Hematology at Kobe University Hospital, together with Associate Professor Goh Ohji of the Division of Infectious Disease Therapeutics and Takaji Matsutani of Anymics Inc., has developed the pGen-SHM plot.

5 Oct 2026

Restoring cellular recycling helps the body clear harmful zombie cells

As we grow older, our bodies accumulate "zombie cells"-living cells that have stopped dividing or functioning normally-but linger in our tissues, contributing to chronic inflammation and age-related diseases.

5 Oct 2026

Cambridge and London Life Sciences Showcase returns during JPM Healthcare Week 2027

o2h co-discovery has announced that the Cambridge × London Life Sciences Showcase will return for its second edition during J.P. Morgan Healthcare Week 2027 in San Francisco.

From o2h Group 5 Oct 2026

BioDuro appoints Greg Makara as Senior Vice President Lead Discovery Chemistry to strengthen early drug discovery capabilities

BioDuro, a global integrated contract research, development and manufacturing organization (CRDMO), today announced the appointment of Greg Makara, Ph.D., as Senior Vice President Lead Discovery Chemistry.

From BioDuro 5 Oct 2026

Dana-Farber research reveals possible new target for treatment of sickle cell and beta thalassemia

That pathway involves BACH2 and NRF2 and was discovered using a large genome-wide association study that enabled an analysis of genes related to fetal hemoglobin from a wide range of ancestries, including European, African, and Asian ancestries.

5 Oct 2026

Shift Bioscience publication increases confidence in AI virtual cells for novel target discovery

Shift Bioscience (Shift), a biotechnology company uncovering the biology of cell rejuvenation to develop new therapies for age driven diseases, today announced the publication of new research in Nature Biotechnology describing an improved calibration framework for deep learning-based genetic perturbation models.

From Shift Bioscience 5 Oct 2026

CN Bio announces expert speaker line-up and scientific program for inaugural Organ-on-a-chip e-Symposium

CN Bio, a leading Organ-on-a-chip (OOC) company de-risking drug discovery and development pipelines by enabling earlier, more confident decision-making, today announced the full scientific program for the 2026 'From Insight to Decision' e-Symposium.

From CN Bio 5 Oct 2026

ESTEVE CDMO expands U.S. capacity with additional $17.5 million investment in Morton Grove

ESTEVE CDMO, a global pure-play CDMO specializing in the development and manufacture of small-molecule APIs and pharmaceutical intermediates, has approved an additional $17.5 million capacity expansion and containment capabilities at its Morton Grove, Illinois facility, bringing total announced investment at the site to $33 million.

From ESTEVE CDMO 5 Oct 2026

Dr. GPCR and Eurofins Discovery join forces to advance GPCR drug discovery

Dr. GPCR, the global knowledge hub for G protein-coupled receptor (GPCR) research and education, today announced a strategic partnership with Eurofins Discovery, the drug discovery services side of the same group behind the Eurofins DiscoverX products many in the community already know.

From Eurofins Discovery 5 Oct 2026

MedPharm inks deal to support global pharmaceutical company with commercial site transfer

MedPharm, a global leader in topical and transdermal contract drug development and manufacturing, today announced that it has signed a new agreement with a global pharmaceutical company to support the commercial site transfer and commercial manufacturing of their branded specialty topical pharmaceutical product.

From MedPharm 5 Oct 2026

New study reveals how VEGF-C amplifies lymphangiogenic signaling

Lymphatic vessels act as the body's "drainage system," collecting excess fluid from tissues. When lymphatic drainage is impaired because lymphatic vessels are underdeveloped, damaged, or dysfunctional, lymphedema can develop, causing swelling, particularly in the arms and legs.

1 Oct 2026

New strategy uncovers bioactive compounds from fragmented metagenomic data

1
2
3
4
...
1144
Next

Life Science News

Specific gene variants influence dental symptoms in rare bone condition

Terumo announces global commercial launch of K-Pack Embrace™ active safety needle

Terumo Blood and Cell Technologies partners with TrAMPoline Pharma to automate TIL therapy manufacturing for solid tumors

Before the first bite: A missing gut protein may set the stage for peanut allergy

Lipid signaling pathway helps cells survive bacterial toxin damage

New BCR analysis method tracks immune recovery after stem cell transplantation

Restoring cellular recycling helps the body clear harmful zombie cells

Cambridge and London Life Sciences Showcase returns during JPM Healthcare Week 2027

BioDuro appoints Greg Makara as Senior Vice President Lead Discovery Chemistry to strengthen early drug discovery capabilities

Dana-Farber research reveals possible new target for treatment of sickle cell and beta thalassemia

Shift Bioscience publication increases confidence in AI virtual cells for novel target discovery

CN Bio announces expert speaker line-up and scientific program for inaugural Organ-on-a-chip e-Symposium

ESTEVE CDMO expands U.S. capacity with additional $17.5 million investment in Morton Grove

Dr. GPCR and Eurofins Discovery join forces to advance GPCR drug discovery

MedPharm inks deal to support global pharmaceutical company with commercial site transfer

New study reveals how VEGF-C amplifies lymphangiogenic signaling

New strategy uncovers bioactive compounds from fragmented metagenomic data

Lab-grown human pituitary cells work and survive after transplantation into a primate

Autophagy changes with age, sex and cell type, study finds

Synthetic protein targets TLR4 membrane region to reduce inflammation

Latest eBooks

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics